New and investigational antiepileptic drugs

Pasquale Striano, Salvatore Striano

Research output: Contribution to journalArticlepeer-review


In the last fifteen years, new antiepileptic medications have been offered for the treatment of patients with epilepsy. Nevertheless, despite optimal medical treatment, up to 30% of patients still experience recurrent seizures and the challenge for new, more efficacious and better-tolerated drugs continues. New antiepileptic drugs include the evolution of pre-existing drugs and new compounds identified through the investigation of additional molecular targets, such as SV2A synaptic vesicle protein, voltage-gated potassium channels, ionotropic and metabotropic glutamate receptors, and gap junctions. This paper reviews the available information on various classes of molecules that are in the pipeline as well as on the innovative approaches to the treatment of epilepsy.

Original languageEnglish
Pages (from-to)1875-1884
Number of pages10
JournalExpert Opinion on Investigational Drugs
Issue number12
Publication statusPublished - Dec 2009


  • Antiepileptic drugs
  • Drug discovery
  • Epilepsy
  • New drugs
  • Therapy

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology


Dive into the research topics of 'New and investigational antiepileptic drugs'. Together they form a unique fingerprint.

Cite this